Amgen Inc (AMGN)
270.74
+1.36
(+0.50%)
USD |
NASDAQ |
Apr 26, 10:10
Amgen Accounts Payable (Quarterly): 1.59B for Dec. 31, 2023
Accounts Payable (Quarterly) Chart
Historical Accounts Payable (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 1.59B |
September 30, 2023 | 1.358B |
June 30, 2023 | 1.212B |
March 31, 2023 | 1.32B |
December 31, 2022 | 1.572B |
September 30, 2022 | 1.204B |
June 30, 2022 | 1.256B |
March 31, 2022 | 1.403B |
December 31, 2021 | 1.366B |
September 30, 2021 | 1.171B |
June 30, 2021 | 1.277B |
March 31, 2021 | 1.396B |
December 31, 2020 | 1.421B |
September 30, 2020 | 1.161B |
June 30, 2020 | 1.15B |
March 31, 2020 | 1.338B |
December 31, 2019 | 1.371B |
September 30, 2019 | 1.005B |
June 30, 2019 | 1.001B |
March 31, 2019 | 1.091B |
December 31, 2018 | 1.207B |
September 30, 2018 | 1.042B |
June 30, 2018 | 1.026B |
March 31, 2018 | 1.089B |
December 31, 2017 | 1.352B |
Date | Value |
---|---|
September 30, 2017 | 879.00M |
June 30, 2017 | 883.00M |
March 31, 2017 | 902.00M |
December 31, 2016 | 917.00M |
September 30, 2016 | 825.00M |
June 30, 2016 | 870.00M |
March 31, 2016 | 818.00M |
December 31, 2015 | 965.00M |
September 30, 2015 | 1.067B |
June 30, 2015 | 934.00M |
March 31, 2015 | 888.00M |
December 31, 2014 | 995.00M |
September 30, 2014 | 955.00M |
June 30, 2014 | 982.00M |
March 31, 2014 | 949.00M |
December 31, 2013 | 787.00M |
September 30, 2013 | 895.00M |
June 30, 2013 | 1.006B |
March 31, 2013 | 940.00M |
December 31, 2012 | 905.00M |
September 30, 2012 | 878.00M |
June 30, 2012 | 884.00M |
March 31, 2012 | 891.00M |
December 31, 2011 | 642.00M |
September 30, 2011 | 734.00M |
Accounts Payable Definition
Accounting terminology for money that a company owes to vendors for services or products that it purchased on credit. Accounts payable appear on the balance sheet as a current liability.
Accounts Payable (Quarterly) Range, Past 5 Years
1.001B
Minimum
Jun 2019
1.59B
Maximum
Dec 2023
1.293B
Average
1.32B
Median
Mar 2023
Accounts Payable (Quarterly) Benchmarks
Gilead Sciences Inc | 550.00M |
Johnson & Johnson | 9.632B |
Eli Lilly and Co | 2.599B |
Merck & Co Inc | 3.922B |
Vertex Pharmaceuticals Inc | 364.90M |